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I
nhibitors of Apoptosis Proteins (IAPs) 
are well-studied E3 ubiquitin ligases 
predominantly known for regulation of 
apoptosis. We uncovered that IAPs can 
function as a direct E3 ubiquitin ligase 
of RhoGTPase Rac1. cIAP1 and XIAP 
directly conjugate polyubiquitin chains 
to Lysine 147 of activated Rac1 and 
target it for proteasomal degradation. 
Consistently, loss of these IAPs by vari-
ous strategies led to stabilization of Rac1 
and mesenchymal mode of migration in 
tumor cells. IAPs also regulate Rac1 deg-
radation upon RhoGDI1 depletion and 
CNF1 toxin treatment. Our observations 
revealed an evolutionarily conserved role 
of IAPs in regulating Rac1 stability shed-
ding light on to the mechanisms behind 
ubiquitination-dependent inactivation of 
Rac1 signaling.
Inhibitors of Apoptosis
Inhibitors of Apoptosis Proteins (IAPs) are 
a class of evolutionarily conserved, multi-
functional proteins primarily character-
ized by the presence of a Baculoviral IAP 
repeat (BIR) domain.1,2 BIR domains are 
classical protein-protein interaction motifs 
with which IAPs directly bind to various 
proteins including caspases. Five IAPs 
including XIAP, cIAP1, cIAP2, ILP2 and 
ML-IAP possess a RING domain with E3 
ubiquitin ligase activity.3 Upon apoptosis 
induction, natural IAP antagonists Smac/
DIABLO, Omi/HtrA2 and ARTS trans-
locate from the mitochondria to release 
IAP-mediated inhibition of caspases.4,5 
XIAP is considered as a direct inhibitor of 
caspases and recent studies revealed an in 
vivo role for the RING domain of XIAP in 
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regulating caspase activation.6,7 cIAPs are 
highly implied in regulating the activation 
of both canonical and non-canonical path-
way of NFκB by functioning as the direct 
E3 ubiquitin ligases of RIPK1 and NIK 
respectively.8 IAPs also function as the 
E3 ubiquitin ligases of RIP2 to regulate 
innate immunity signaling.9 Further, IAPs 
are highly expressed in tumor cells and 
cIAP1 was recognized as an oncogene.1,10 
Recent studies revealed that depletion of 
IAPs has led to sensitization of tumor cells 
to conventional chemotherapeutic drugs. 
These results have emboldened scientists 
to pursue for IAP antagonists to treat 
cancers and several of these drugs (anti-
sense nucleotides and Smac mimetics) are 
already in clinical trials.2
IAPs Directly Regulate Rac1  
and Cell Shape
We have recently uncovered that IAPs also 
control the RAF/MEK/ERK1/2 pathway 
and cell migration by directly regulating 
the stability of C-RAF kinase.11 These 
observations have raised an important 
question. Does treatment with IAP antag-
onists also lead to an increase in C-RAF 
levels and cell migration? To address 
this issue we have treated several tumor 
cell lines with various concentrations of 
IAP antagonist compound (BV6/IAC). 
Previous studies have shown that these 
compounds trigger the autoubiquitination 
of cIAPs leading to NIK stabilization and 
activation of the non-canonical NFκB 
pathway. This in turn leads to the pro-
duction of TNFα and cell death in a cell 
type dependent manner.12,13 Treatment of 
HeLa cells with IACs promoted cell death © 2012 Landes Bioscience.
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remained elusive. Ubiquitination is a most 
versatile form of posttranslational modi-
fication where proteins are covalently 
conjugated to ubiquitin in a three-step 
process.22 Proteins can be conjugated with 
single ubiquitin on one lysine or on mul-
tiple lysines (mono-or multi-mono ubiq-
uitination) or as polyubiquitin chains of 
various kinds.23 Proteins conjugated with 
K-48 or K-29 linked ubiquitin chains are 
normally doomed for proteasomal deg-
radation while the proteins tagged with 
K-63 linked or M1 linked chains lead to 
assemblage of protein complexes and sig-
nal transduction.24 E3 ubiquitin ligases 
constitute the third step of the ubiquitina-
tion process and play an obligatory role in 
catalyzing the conjugation of ubiquitin to 
a lysine residue in the target proteins. The 
chain initiation, elongation and topology 
are, however, primarily controlled by the 
E2 enzymes.25 RhoGTPases were ini-
tially observed to be degraded via protea-
somes during host-pathogen interactions. 
Cytotoxic Necrotizing factor 1 (CNF1), 
a toxin secreted by uropathogenic E. coli, 
has been shown to constitutively activate 
RhoGTPases by deamidation leading to 
their proteasomal degradation.26 While 
Smurf1 and Cullins (Cul3) were shown 
to regulate the polyubiquitination and 
degradation of RhoA, the E3 ligases driv-
ing Rac1 polyubiquitination were not 
known.21 Our observations unexpectedly 
revealed a role of IAPs in the inactivation 
of Rac1 by direct polyubiquitination and 
levels. However, to our surprise, there was 
a modest increase (1.5- to 2-fold) in the 
total Rac1 protein levels in IAC treated 
cells which has led to the notion that 
IAPs might regulate the stability of Rac1 
directly. Indeed, loss of XIAP or cIAP1 by 
siRNAs or genetic deletion has led to an 
increase in total Rac1 levels in several cell 
lines.14 Further studies revealed that IAPs 
could directly bind Rac1 in a nucleotide 
independent manner and catalyze the 
conjugation of polyubiquitin chains lead-
ing to its proteasomal degradation. By 
applying mass spectrometric approaches, 
we have detected that XIAP and cIAP1 
can directly conjugate ubiquitin to Lysine 
147 of Rac1, a major ubiquitination site 
already shown to be responsible for regu-
lating Rac1 stability.14,17
Ubiquitin Dependent Regulation 
of Rac1: Role for IAPs and HACE1
Rac1 is a well-studied RhoGTPase, which 
controls numerous cellular functions.18 
Apart from nucleotide binding and iso-
prenylation, Rho GTPases are also regu-
lated by phosphorylation, SUMOylation 
and ubiquitination.19-21 The binding of 
nucleotides to Rac1 is regulated by sev-
eral GEFs and GAPs and a recent study 
from Angeliki Malliri’s group has revealed 
a role for PIAS3 for SUMOylation of 
Rac1.20 Though Rac1 has been shown 
to be polyubiquitinated, the E3 ubiq-
uitin ligases responsible for this process 
in a TNFα-dependent manner and when 
combined with a pro-death ligand like 
TRAIL there was massive sensitization of 
these cells to apoptosis. However, when 
employed at sublethal doses, IACs trig-
gered a complete loss of cIAP1 and par-
tial loss of other IAPs (cIAP2 and XIAP) 
in a concentration and time dependent 
manner leading to an increase in C-RAF 
levels and enhanced transwell migration 
of HeLa cells.14 Intriguingly, most of the 
IAC treated HeLa cells exhibited highly 
elongated morphology with protruding 
lamellipodia irrespective of the substrate 
on which they were grown (Fig. 1). These 
effects are also detected in other tumor 
cell lines (HT1080, WM852 and A549) 
as well as in immortalized human mam-
mary epithelial cells. While the migration 
of IAC-treated HeLa cells is dependent on 
MAPK activation, the formation of elon-
gated morphology was not inhibited by 
the treatment of cells with MEK inhibi-
tor U0126. Tumour cells exhibit primarily 
two different modes of migration depend-
ing on the extracellular cues: RhoA depen-
dent amoeboid mode and Rac1 dependent 
mesenchymal mode and the cells switch 
from one mode to another depending on 
matrix density and composition.15,16 As 
IAC treated cells exhibited amoeboid to 
mesenchymal transition (AMT), we have 
tested for the activation status of Rac1 
and RhoA. As expected, Rac1-GTP lev-
els increased upon IAC treatment with 
concomitant reduction in RhoA-GTP 
Figure 1. Loss of IAPs trigger AMT in HeLa cells. HeLa cells seeded on gelatine coated plates were treated with 5 μM of IAC. The morphological 
changes were monitored by phase contrast microscopy.© 2012 Landes Bioscience.
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degradation of RhoGTPases including 
Rac1.30 Our observations suggest that 
XIAP is required for degradation of Rac1 
upon RhoGDI1 depletion. As IAPs are 
predominantly cytosolic, it is tempting to 
propose that XIAP might primarily target 
the cytosolic pool of Rac1 in cells (Fig. 2). 
Obviously there will be a significant con-
tribution of other Rac1 effectors like cave-
olin in regulating the interaction between 
Rac1 and its E3 ligases (Fig. 2).31 In these 
lines, it is interesting to point out that an 
interaction between XIAP and caveolin-1 
has been demonstrated before.32 Previous 
studies have revealed that nuclear localiza-
tion and interaction with karyopherin α2 
are prerequisites for CNF1-mediated Rac1 
degradation.33 It is not clear, if HACE1 
is localized to the nucleus and if HACE1 
interacts with other known Rac1 effectors. 
In these lines, it is interesting to point out 
that cIAP1 has been shown to be shuttling 
to clarify if any of the three BIR domains 
exhibit preferential specificity for binding 
to Rac1. Though IAPs bind to Rac1Q61L 
and Rac1T17N, activated Rac1 seems to 
be a better substrate of cIAP1 at least in 
vitro in the presence of Ubc5Ha as an E2 
enzyme. As XIAP can also ubiquitinate 
directly, it is plausible that XIAP-cIAP1 
complex would function as a more effi-
cient ubiquitin ligase in vivo and heterom-
erization between XIAP and cIAP1 has 
been demonstrated before.28,29 Depletion 
of either XIAP or cIAP1 or both has led to 
an identical increase in Rac1 levels. These 
results suggest that IAPs are functionally 
non-redundant in regulating Rac1 levels 
though we cannot completely rule out the 
possibility that these two IAPs might con-
trol two different subcellular pools of Rac1. 
Most of the Rac1 protein is localized to 
the cytosol in complex with RhoGDI and 
depletion of RhoGDI1 leads to a strong 
proteasomal degradation under various 
conditions including CNF1 toxin treat-
ment.14 Apart from IAPs, elegant work 
from Emmanuel Lemichez and colleagues 
has also revealed a role for HACE1 for 
polyubiquitination of Rac1.27 HACE1, 
unlike IAPs carries a HECT domain 
to catalyze polyubiquitination of Rac1. 
Interestingly, HACE1 preferentially binds 
to the GTP-bound form of Rac1 while 
IAPs can bind to Rac1 irrespective of its 
activation status. These results suggest 
that IAPs are probably binding to the 
C-terminus of Rac1. Further IAPs can 
also bind to Rac2 and Rac3 though these 
isoforms are not regulated by IAP expres-
sion. In addition, IAP overexpression has 
failed to influence the protein levels of 
Rac1b, a tumor associated splice variant 
of Rac1. Binding of XIAP to Rac1 was 
independent of BIR3, UBA and RING 
domains and further studies are required 
Figure 2. IAPs and HACE1 directly interact with Rac1 and promotes its polyubiquitination. Binding of Rac1 to GEFs and GAPs controls activation-
inactivation cycle of Rac1. Most of Rac1 is sequestered to RhoGDI in the cytosol in GDP bound form preventing it from degradation. Activated Rac1 is 
membrane bound and is maintained in the GTP-bound state by PIAS-mediated SUMOylation leading to tumor cell migration and invasion. Free Rac1 
in the cytosol is unstable and is ubiquitinated by IAPs leading to its degradation via the ubiquitin-proteasome system (UPS) in the cytosol or nucleus. 
CNF1 toxin leads to deamidation of Rac1 at Q61, which leads to persistent activation, nuclear shuttling and thus predisposing it for degradation by 
ubiquitination via IAPs or HACE1. IAPs directly ubiquitinate Rac1 at lysine 147 leading to its proteasomal degradation. For simplicity isoprenylation of 
Rac1 is avoided.© 2012 Landes Bioscience.
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IAPs. While our studies are primarily 
based on HeLa cells, Lopez et al. employed 
MCF-7 cells in their analysis. Similarly, 
Liu et al. primarily employed shRNAs 
or genetic deletion in human tumor cell 
lines to downregulate XIAP in contrast 
to our loss of function studies, which are 
primarily based on transient downregula-
tion of IAPs by employing siRNAs and 
IAC. However, this issue needs to be rec-
onciled as we have detected an increase in 
Rac1 levels upon IAP depletion in mul-
tiple cell types including MCF-7 cells and 
SV40 transformed MEFs derived from 
XIAP deficient mice have also exhibited 
enhanced migration and wound healing 
under our experimental settings. Further, 
by creating a transgenic adenocarcinoma 
of the mouse prostate (TRAMP) mice that 
lack XIAP, Collin Duckett and colleagues 
have shown that loss of XIAP has actually 
led to an aggressive form of disease.41 In a 
more recent study, Dario Altieri and col-
leagues have shown that XIAP-survivin 
complex can promote metastases in a 
NFκB dependent manner.42 Whether our 
current results have any relevance to these 
observed phenotypes in mice deserves 
further investigations. As downregula-
tion of IAPs enhanced cell migration, 
one obvious concern is that treatment 
with IAP antagonists might unexpect-
edly promote the metastases of surviving 
tumor cells. However, this may not neces-
sarily be the case as increased Rac1 levels 
can be compensated by co-regulation of 
GAPs and GEFs. Further, Rac1 activ-
ity has been shown to both promote and 
inhibit tumor cell invasion in a cell type 
dependent manner. For instance, ectopic 
expression of Tiam1, a Rac1 GEF or acti-
vated Rac1 actually led to an increase in 
E-cadherin mediated cell adhesion and 
loss of invasiveness in RAS-transformed 
MDCK cells.43 However, Rac isoforms 
are found to be highly expressed in tumor 
cells and overexpression of Rac1 GEFs 
like P-Rex is often detected in invasive 
breast cancer cells.38,44 Rac1 is also shown 
to be required for K-Ras-mediated lung 
tumor formation.45 Thus, IAP-mediated 
Rac1 regulation might regulate tumor cell 
migration in a tissue/cell type dependent 
manner. As IAP antagonists are primar-
ily pursued in combination with other 
chemotherapeutics in clinical trials, one 
severe developmental defects in XIAP-
cIAP1 double deficient mice. Further, it 
would be interesting to learn if there is 
any cross talk between IAPs and HACE1 
and their relative contribution in regulat-
ing Rac1 levels under various conditions 
(Fig. 2). IAP mediated regulation of Rac1 
is evolutionarily conserved as DIAP1, an 
IAP from Drosophila has been shown to 
bind to Rac1 in a nucleotide independent 
manner.35 We have extended on these 
observations and uncovered that Danio 
rerio XIAP can also bind to Rac1 in a 
nucleotide independent manner. Further, 
in collaboration with Reinhard Koster’s 
lab we have examined the role of Dr-XIAP 
in regulating cerebellar granule cell migra-
tion during zebrafish brain development. 
During vertebrate development, the 
cerebellar granule cells (CGNs) exhibit 
highly directional migration from the 
Upper Rhombic Lip to form the cerebel-
lum.36 These cells primarily express Rac1 
isoform and migrate collectively as chain-
like structures in a Cadherin-2 dependent 
manner.37 Interestingly, increasing XIAP 
in these cells has led to the formation of 
rounded cells, which delaminate from the 
tissue architecture and are often found 
in the cerebrospinal fluid present in the 
fourth ventricle. These effects are clearly 
Rac1 dependent as co-expression of Rac1 
with XIAP can partially rescue the pheno-
type.14 Further, depletion of XIAP using 
siRNAs has led to a strong increase in 
Rac1 levels in the immortalized cerebel-
lar granule cells derived from mice. The 
delamination phenotype observed in 
XIAP overexpressing CGNs resembles 
medulloblastoma which originates from 
CGN cells. These observations reveal an 
in vivo role of XIAP in regulating progeni-
tor cell migration by directly controlling 
Rac1 homeostasis during brain develop-
ment of a vertebrate organism.
Role of IAPs in Regulating Tumor 
Cell Migration and Metastases
The role of IAPs in regulating cell migra-
tion remains controversial, as two other 
labs have detected a role for IAPs in pro-
moting cell migration.39,40 The apparent 
discrepancy can be attributed to the dif-
ference in the cell types employed or on 
the strategy adopted to downregulate 
to the nucleus in many cell types. IAPs 
have been shown to synthesize various 
kinds of ubiquitin chains in vitro and in 
vivo. While HACE1 exploits UbcH7 as an 
E2 enzyme, dimerized RING domains of 
IAPs primarily interact with Ubc5H sub-
family members for its auto-, cross- and 
substrate ubiquitination. Improved mass 
spectrometric analysis would enable to 
unveil the kind of ubiquitin chains being 
synthesized on Rac1 at endogenous levels 
by these E3 ligases. In addition, further 
analysis of in vitro ubiquitination of Rac1 
with IAPs revealed that ubiquitin could 
also be conjugated by IAPs to other lysines 
in Rac1. Currently, we are investigating 
the biological significance of these obser-
vations. As Rac1 is also SUMOylated 
by PIAS (primarily at Lysines 188, 183 
and 184 or 186 in the Poly basic region) 
it would be interesting to decipher the 
cross-talk between ubiquitination and 
SUMOylation in regulating Rac1 func-
tion. SUMOylated Rac1 may be protected 
from being recognised by the E3 ubiquitin 
ligases so as to sustain Rac1-GTP levels to 
facilitate cell migration and invasion.38
Role of XIAP in Regulating Cell 
Migration during Vertebrate  
Development
Mammals express eight IAPs and mice 
deficient in individual IAPs lack any 
major developmental phenotypes. As 
IAPs directly regulate Rac1 levels, lack of 
any major migration phenotypes during 
development of mice is indeed intrigu-
ing. This could be attributed to the pres-
ence of other E3 ligases for Rac1 (like 
HACE1) and cross regulation between 
the IAPs. IAPs are constitutively orga-
nized into heteromeric protein complexes 
(IAPosomes) and loss of one IAP leads to 
an increase in the protein levels of another 
IAP.29 For instance, loss of cIAP1 led to 
an increase in the protein levels of cIAP2 
and vice versa.34 Our unpublished obser-
vations further suggest that XIAP can also 
regulate the protein levels of cIAP1. This 
is evident in the experiments performed 
with MEFs derived from XIAP deficient 
mice as increased Rac1 levels observed in 
these early passage MEFs were cleared off 
at later passages possibly due to upregu-
lation of cIAP1. Thus we would expect © 2012 Landes Bioscience.
Do not distribute.
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would expect sensitization of tumor cells 
to apoptosis. However, if the cells survive 
there may be a risk of promoting tumor 
cell invasion by loss of IAPs through an 
increase in CRAF and Rac1 levels (Fig. 
3). Indeed dual targeting of IAPs and 
Rac1 effector PAK1 has been shown to be 
effective in inducing effector caspase acti-
vation and apoptosis in NSCLC tumor 
cells.46 A better understanding of the role 
of IAPs in regulating tumor cell migra-
tion and invasion will assist in patient 
selection as well as to adroitly administer 
IAP antagonist compounds in treating a 
complex disease like cancer. The discovery 
of IAPs and HACE1 as the E3 ubiquitin 
ligases of Rac1 has revealed the molecular 
mechanisms behind polyubiquitination of 
Rac1, a thus far uncharacterized layer of 
regulation apart from GEFs, GAPs and 
RhoGDIs.
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